These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23715464)

  • 1. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation.
    van Rosmalen J; Toy M; O'Mahony JF
    Med Decis Making; 2013 Aug; 33(6):767-79. PubMed ID: 23715464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous-Time Semi-Markov Models in Health Economic Decision Making: An Illustrative Example in Heart Failure Disease Management.
    Cao Q; Buskens E; Feenstra T; Jaarsma T; Hillege H; Postmus D
    Med Decis Making; 2016 Jan; 36(1):59-71. PubMed ID: 26174352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods.
    Elbasha EH; Chhatwal J
    Med Decis Making; 2016 Jan; 36(1):115-31. PubMed ID: 26092831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Method for Model-Based Health Economic Evaluation Utilizing and Extending Moment-Generating Functions.
    Snowsill T
    Med Decis Making; 2019 Jul; 39(5):523-539. PubMed ID: 31319752
    [No Abstract]   [Full Text] [Related]  

  • 5. A piecewise-homogeneous Markov chain process of lung transplantation.
    Sharples LD; Taylor GI; Faddy M
    J Epidemiol Biostat; 2001; 6(4):349-55. PubMed ID: 12036269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Markov Models with Discontinuities.
    Pérez-Martín J; Bermejo I; Díez FJ
    Med Decis Making; 2019 May; 39(4):414-420. PubMed ID: 30920897
    [No Abstract]   [Full Text] [Related]  

  • 7. Discrete event simulation: the preferred technique for health economic evaluations?
    Caro JJ; Möller J; Getsios D
    Value Health; 2010 Dec; 13(8):1056-60. PubMed ID: 20825626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The half-cycle correction revisited: redemption of a kludge.
    Naimark DM; Kabboul NN; Krahn MD
    Med Decis Making; 2013 Oct; 33(7):961-70. PubMed ID: 24048350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The half-cycle correction explained: two alternative pedagogical approaches.
    Naimark DM; Bott M; Krahn M
    Med Decis Making; 2008; 28(5):706-12. PubMed ID: 18448700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markov models in medical decision making: a practical guide.
    Sonnenberg FA; Beck JR
    Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy, Sick, Dead - An Educational Blueprint to State Transition Disease Modelling.
    Schramm W; Rickmann J; Sailer F
    Stud Health Technol Inform; 2017; 238():223-226. PubMed ID: 28679929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A continuous time version and a generalization of a Markov-recapture model for trapping experiments.
    Alpizar-Jara R; Smith CE
    Math Biosci; 2008; 214(1-2):11-9. PubMed ID: 18556026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis.
    Hiligsmann M; Ethgen O; Bruyère O; Richy F; Gathon HJ; Reginster JY
    Value Health; 2009; 12(5):687-96. PubMed ID: 19508659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.
    Chhatwal J; Jayasuriya S; Elbasha EH
    Med Decis Making; 2016 Nov; 36(8):952-64. PubMed ID: 27369084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding Events to a Markov Model Using DICE Simulation.
    Caro JJ; Möller J
    Med Decis Making; 2018 Feb; 38(2):235-245. PubMed ID: 28675959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An introduction to Markov modelling for economic evaluation.
    Briggs A; Sculpher M
    Pharmacoeconomics; 1998 Apr; 13(4):397-409. PubMed ID: 10178664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder.
    Vataire AL; Aballéa S; Antonanzas F; Roijen LH; Lam RW; McCrone P; Persson U; Toumi M
    Value Health; 2014 Mar; 17(2):183-95. PubMed ID: 24636376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A numerical approach for a discrete Markov model for progressing drug resistance of cancer.
    Maeda M; Yamashita H
    PLoS Comput Biol; 2019 Feb; 15(2):e1006770. PubMed ID: 30779730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-Markov Arnason-Schwarz models.
    King R; Langrock R
    Biometrics; 2016 Jun; 72(2):619-28. PubMed ID: 26584064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment.
    Jahn B; Rochau U; Kurzthaler C; Paulden M; Kluibenschädl M; Arvandi M; Kühne F; Goehler A; Krahn MD; Siebert U
    Med Decis Making; 2016 Apr; 36(3):375-90. PubMed ID: 26476865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.